German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany
Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)
Germany finally approved Optune under their national health system.
I thought the USA was slow - Medicare approved it last year - about 4 years after it was approved for newly diagnosed glioblastoma.
It is troubling that there is such a delay between FDA approval and insurance payment approval. The same thing happened with Temodar and Avastin. In the USA, the Medicare approval process should start at the same time as the application to the FDA so the FDA and Medicare approvals come out at the same time.
Posted on: 03/20/2020
Click HERE to return to brain tumor news headlines